ArticleCureus2026

Thanatophoric Dysplasia Type I Confirmed by Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation: Clinical Course and Ethical Considerations.

Maria I Soares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.